世界のナルコレプシー治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03907)
◆英語タイトル:Global Narcolepsy Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV03907
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:94
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはナルコレプシー治療の世界市場について調査・分析した資料です。種類別(オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他)の市場規模、用途別(脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ナルコレプシー治療の競争状況、市場シェア
・世界のナルコレプシー治療市場:種類別市場規模 2015年-2020年(オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他)
・世界のナルコレプシー治療市場:種類別市場規模予測 2021年-2026年(オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他)
・世界のナルコレプシー治療市場:用途別市場規模 2015年-2020年(脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー)
・世界のナルコレプシー治療市場:用途別市場規模予測 2021年-2026年(脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー)
・北米のナルコレプシー治療市場分析:米国、カナダ
・ヨーロッパのナルコレプシー治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのナルコレプシー治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のナルコレプシー治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのナルコレプシー治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Teva Pharmaceutical、Takeda、Jazz Pharmaceuticals、Arena Pharmaceuticals、Graymark Healthcare、Ligand Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.
By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimulants, sodium oxybate, and antidepressants.

Market Analysis and Insights: Global Narcolepsy Treatment Market
The global Narcolepsy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Narcolepsy Treatment Scope and Market Size
Narcolepsy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals

Market segment by Type, the product can be split into
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
Market segment by Application, split into
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Narcolepsy Treatment Revenue
1.4 Market by Type
1.4.1 Global Narcolepsy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sodium Oxybate
1.4.3 Antidepressants
1.4.4 Central Nervous System Stimulants
1.4.5 Others
1.5 Market by Application
1.5.1 Global Narcolepsy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Primary Narcolepsy with Cataplexy
1.5.3 Primary Narcolepsy without Cataplexy
1.5.4 Narcolepsy Due to Medical Conditions
1.5.5 Unspecified Narcolepsy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Narcolepsy Treatment Market Perspective (2015-2026)
2.2 Global Narcolepsy Treatment Growth Trends by Regions
2.2.1 Narcolepsy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Narcolepsy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Narcolepsy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Narcolepsy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Narcolepsy Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Treatment Players by Market Size
3.1.1 Global Top Narcolepsy Treatment Players by Revenue (2015-2020)
3.1.2 Global Narcolepsy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Narcolepsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Narcolepsy Treatment Market Concentration Ratio
3.2.1 Global Narcolepsy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Treatment Revenue in 2019
3.3 Narcolepsy Treatment Key Players Head office and Area Served
3.4 Key Players Narcolepsy Treatment Product Solution and Service
3.5 Date of Enter into Narcolepsy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Narcolepsy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Narcolepsy Treatment Market Size by Application (2015-2020)
5.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Narcolepsy Treatment Market Size (2015-2020)
6.2 Narcolepsy Treatment Key Players in North America (2019-2020)
6.3 North America Narcolepsy Treatment Market Size by Type (2015-2020)
6.4 North America Narcolepsy Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Narcolepsy Treatment Market Size (2015-2020)
7.2 Narcolepsy Treatment Key Players in Europe (2019-2020)
7.3 Europe Narcolepsy Treatment Market Size by Type (2015-2020)
7.4 Europe Narcolepsy Treatment Market Size by Application (2015-2020)

8 China
8.1 China Narcolepsy Treatment Market Size (2015-2020)
8.2 Narcolepsy Treatment Key Players in China (2019-2020)
8.3 China Narcolepsy Treatment Market Size by Type (2015-2020)
8.4 China Narcolepsy Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Narcolepsy Treatment Market Size (2015-2020)
9.2 Narcolepsy Treatment Key Players in Japan (2019-2020)
9.3 Japan Narcolepsy Treatment Market Size by Type (2015-2020)
9.4 Japan Narcolepsy Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Narcolepsy Treatment Market Size (2015-2020)
10.2 Narcolepsy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Narcolepsy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Narcolepsy Treatment Market Size by Application (2015-2020)

11 India
11.1 India Narcolepsy Treatment Market Size (2015-2020)
11.2 Narcolepsy Treatment Key Players in India (2019-2020)
11.3 India Narcolepsy Treatment Market Size by Type (2015-2020)
11.4 India Narcolepsy Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Narcolepsy Treatment Market Size (2015-2020)
12.2 Narcolepsy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Narcolepsy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Narcolepsy Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Details
13.1.2 Teva Pharmaceutical Business Overview
13.1.3 Teva Pharmaceutical Narcolepsy Treatment Introduction
13.1.4 Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2015-2020))
13.1.5 Teva Pharmaceutical Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview
13.2.3 Takeda Narcolepsy Treatment Introduction
13.2.4 Takeda Revenue in Narcolepsy Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Jazz Pharmaceuticals
13.3.1 Jazz Pharmaceuticals Company Details
13.3.2 Jazz Pharmaceuticals Business Overview
13.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Introduction
13.3.4 Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.3.5 Jazz Pharmaceuticals Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Narcolepsy Treatment Introduction
13.4.4 Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 Graymark Healthcare
13.5.1 Graymark Healthcare Company Details
13.5.2 Graymark Healthcare Business Overview
13.5.3 Graymark Healthcare Narcolepsy Treatment Introduction
13.5.4 Graymark Healthcare Revenue in Narcolepsy Treatment Business (2015-2020)
13.5.5 Graymark Healthcare Recent Development
13.6 Ligand Pharmaceuticals
13.6.1 Ligand Pharmaceuticals Company Details
13.6.2 Ligand Pharmaceuticals Business Overview
13.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Introduction
13.6.4 Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.6.5 Ligand Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Teva Pharmaceutical、Takeda、Jazz Pharmaceuticals、Arena Pharmaceuticals、Graymark Healthcare、Ligand Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のナルコレプシー治療市場2026:インサイト・予測(Global Narcolepsy Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。